Rasha Al-Lamee(@rallamee) 's Twitter Profileg
Rasha Al-Lamee

@rallamee

Interventional Cardiology Consultant, Clinical Trialist, Imperial College London. Wife to a rugby obsessed husband and mum to a football obsessed son

ID:916585888574042113

calendar_today07-10-2017 08:47:59

1,5K Tweets

5,6K Followers

546 Following

Follow People
Matthew Shun-Shin(@mshunshin) 's Twitter Profile Photo

As ever, with the statistical methods developed by Frank Harrell, the 22,823 patient-days of symptoms data are utilised, based on work detailed here: youtube.com/watch?v=FI2ncR…. Perhaps one day Bayesian ordinal longitudinal models will be used by all trials...

account_circle
Matthew Shun-Shin(@mshunshin) 's Twitter Profile Photo

Rasha Al-Lamee JACC Journals Christopher Rajkumar In a secondary analysis of ORBITA2, Florentina Simader tested how the presence or absence of the classical features of angina, as defined by Rose 1962 definition predicted the placebo-controlled response to PCI.

@rallamee @JACCJournals @rajkumar_chris In a secondary analysis of ORBITA2, @FloSimader tested how the presence or absence of the classical features of angina, as defined by Rose 1962 definition predicted the placebo-controlled response to PCI.
account_circle
Matthew Shun-Shin(@mshunshin) 's Twitter Profile Photo

Rasha Al-Lamee JACC Journals In an innovative n-of-1 study with real and placebo balloon inflations, Christopher Rajkumar asked patients how similar the associated pain was to their everyday symptoms to derive a 'similarity score'. This score strongly predicted their subsequent improvement in angina after PCI.

@rallamee @JACCJournals In an innovative n-of-1 study with real and placebo balloon inflations, @rajkumar_chris asked patients how similar the associated pain was to their everyday symptoms to derive a 'similarity score'. This score strongly predicted their subsequent improvement in angina after PCI.
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

.Florentina Simader on -2 at :
📌Poor correlation between symptoms & disease severity
📌Symptom nature is a powerful predictor of the placebo-controlled efficacy of
📌Rose angina & typical angina are excellent predictors of the placebo-controlled efficacy of PCI

.@FloSimader on #ORBITA-2 at #EuroPCR: 📌Poor correlation between symptoms & disease severity 📌Symptom nature is a powerful predictor of the placebo-controlled efficacy of #PCI 📌Rose angina & typical angina are excellent predictors of the placebo-controlled efficacy of PCI
account_circle
Matthew Shun-Shin(@mshunshin) 's Twitter Profile Photo

Fantastic to see two new studies from Rasha Al-Lamee's ORBITA programme, presented at and simultaneously published in JACC Journals. ORBITA2 found PCI was an effective anti-anginal procedure. However, do all patients benefit similarly? How important is the nature of symptoms?

account_circle
Frank Harrell(@f2harrell) 's Twitter Profile Photo

Collaborating with researchers who are bold enough to be truly innovative in clinical research including being all-in on Bayes is an absolute joy. Go ÓRBITA team!! Rasha Al-Lamee Matthew Shun-Shin

account_circle
Rasha Al-Lamee(@rallamee) 's Twitter Profile Photo

As always my team make me very proud. Today we launched our newest ORBITA fellow Florentina Simader who did the most fabulous job of explaining how symptoms predict outcomes from ORBITA-2 JACC Journals Matthew Shun-Shin

As always my team make me very proud. Today we launched our newest ORBITA fellow @FloSimader who did the most fabulous job of explaining how symptoms predict outcomes from ORBITA-2 @JACCJournals @mshunshin
account_circle
Antonin Trimaille(@A_Trimaille) 's Twitter Profile Photo

🔥 Important new insights from ORBITA-2 study presented today at

👉🏼 More angina symptoms do not necessarily reflect more extended coronary disease

👉🏼 The clinical history is a strong predictor of the efficacy of PCI

🚨Interroge your patients!

PCRonline 🫀 Rasha Al-Lamee

🔥 Important new insights from ORBITA-2 study presented today at #EuroPCR 👉🏼 More angina symptoms do not necessarily reflect more extended coronary disease 👉🏼 The clinical history is a strong predictor of the efficacy of PCI 🚨Interroge your patients! @PCRonline @rallamee
account_circle
Raffaele Di Giacomo, PhD(@sciqst) 's Twitter Profile Photo

JACC Journals Florentina Simader Rasha Al-Lamee The -2 study brings intriguing insights. It seems symptom nature rather than severity drives the efficacy of in a placebo-controlled context. This suggests that patient-reported outcomes should be a key focus in treatment planning. For detailed analyses and

account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

LBCT SimPub: Insights from -BCIS2 trial - Completeness of , whether anatomical or viability-guided, does not influence outcomes in patients with ischemic . bit.ly/44JRcV0

Saad Ezad Margaret McEntegart Cardiac Research

#EuroPCR #JACC LBCT SimPub: Insights from #REVIVED-BCIS2 trial - Completeness of #revascularization, whether anatomical or viability-guided, does not influence outcomes in patients with ischemic #cardiomyopathy. bit.ly/44JRcV0 @SaadEzad @mbmcentegart @UKheartresearch
account_circle
JACC Journals(@JACCJournals) 's Twitter Profile Photo

LBCT SimPub: -2 symptom-stratified analysis - Although symptom severity & nature were poorly associated with disease severity, the nature of symptoms powerfully predicted the placebo-controlled efficacy of . bit.ly/3QK76cj

Florentina Simader Rasha Al-Lamee

#EuroPCR #JACC LBCT SimPub: #ORBITA-2 symptom-stratified analysis - Although symptom severity & nature were poorly associated with disease severity, the nature of symptoms powerfully predicted the placebo-controlled efficacy of #PCI. bit.ly/3QK76cj @FloSimader @rallamee
account_circle
Mona Tirén(@monaltiren) 's Twitter Profile Photo

🙏Thanks JACC Journals
for this discussion about

The Influence of
Epicardial Resistance on Microvascular Resistance Reserve

👇
youtu.be/768iGJwNzss

👋 Bernard De Bruyne
Thabo Mahendiran
Rasha Al-Lamee

🙏Thanks @JACCJournals for this discussion about The Influence of Epicardial Resistance on Microvascular Resistance Reserve 👇 youtu.be/768iGJwNzss 👋 @BernardBruyne Thabo Mahendiran @rallamee
account_circle